Solid Carcinoma Clinical Trials

14 recruitingLast updated: June 17, 2026

There are 14 actively recruiting solid carcinoma clinical trials across 6 countries. Studies span Phase 1, Not Applicable, Phase 2, Phase 3. Top locations include Houston, Texas, United States, New York, New York, United States, San Francisco, California, United States. Updated daily from ClinicalTrials.gov.


Solid Carcinoma Trials at a Glance

14 actively recruiting trials for solid carcinoma are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 1 with 10 trials, with the heaviest enrollment activity in Houston, New York, and San Francisco. Lead sponsors running solid carcinoma studies include Asan Medical Center, Memorial Sloan Kettering Cancer Center, and Xadcera Biopharmaceutical (Suzhou) Co., Ltd..

Browse solid carcinoma trials by phase

Treatments under study

About Solid Carcinoma Clinical Trials

Looking for clinical trials for Solid Carcinoma? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Solid Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Solid Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 1

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

Advanced Solid TumorMetastatic Solid TumorSolid Tumor+2 more
Memorial Sloan Kettering Cancer Center16 enrolled7 locationsNCT07638371
Recruiting
Phase 1

PET [89Zr]DFO-starPEG in Solid Tumors

Solid TumorSolid CarcinomaSoft Tissue Lesion
Robert Flavell, MD, PhD13 enrolled1 locationNCT06894745
Recruiting
Phase 2Phase 3

Trop2-targeted immunoPET Imaging of Solid Tumors

Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Not Applicable

Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

Solid Carcinoma
Asan Medical Center60 enrolled1 locationNCT04264975
Recruiting
Phase 1Phase 2

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Colorectal, CancerColorectal CarcinomaNon-small Cell Lung Cancer+29 more
Institut de Recherches Internationales Servier554 enrolled11 locationsNCT05786924
Recruiting
Phase 1

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

CancerSolid Tumor, AdultCancer, Metastatic+3 more
Shenzhen Ionova Life Sciences Co., Ltd.78 enrolled3 locationsNCT04443088
Recruiting
Phase 1

A Study of Avutometinib for People With Solid Tumor Cancers

Solid TumorSolid Tumor, AdultNeuroblastoma+12 more
Memorial Sloan Kettering Cancer Center23 enrolled2 locationsNCT06104488
Recruiting
Not Applicable

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk

Solid Carcinoma
Institut Cancerologie de l'Ouest200 enrolled1 locationNCT06051214
Recruiting
Phase 1

A Study of DM002 in Patients With Advanced Solid Tumors

Ovarian NeoplasmsColorectal NeoplasmsEndometrial Neoplasms+2 more
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.160 enrolled5 locationsNCT06751329
Recruiting
Phase 1

A Study of DM005 in Patients With Advanced Solid Tumors

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckSolid Carcinoma
Doma Biopharmaceutical(Suzhou)Co., Ltd.136 enrolled6 locationsNCT06515990
Recruiting
Not Applicable

FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy

Solid Carcinoma
Asan Medical Center50 enrolled1 locationNCT05533983
Recruiting
Phase 1

Imaging of Solid Tumors Using 18F-TRX

Metastatic Malignant Solid NeoplasmStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+7 more
Rahul Aggarwal56 enrolled1 locationNCT06942104
Recruiting
Phase 1

A Study of DM001 in Patients With Advanced Solid Tumors

Breast NeoplasmsCarcinoma, Non-Small Cell LungSolid Carcinoma
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.128 enrolled5 locationsNCT06475937
Recruiting
Phase 1

PRE-I-SPY Phase I/Ib Oncology Platform Program

Triple-Negative Breast CancerMetastatic Breast CancerHER2-low Breast Cancer+18 more
QuantumLeap Healthcare Collaborative124 enrolled7 locationsNCT05868226